Clincosm LogoSign in Get a demo

Non-Small-Cell Lung Cancer

Showing 26 - 50 of 120
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

The Research Plan of Taiwan Precision Medicine

Not yet recruiting
  • Non-small-cell Lung Cancer
    • Dalin, Taiwan
    • +8 more
    Apr 15, 2021

    Non-Small-Cell Lung Cancer Trial in Japan (LDK378)

    Completed
    Has Results
    • Non-Small-Cell Lung Cancer
    • Nagoya, Aichi, Japan
    • +8 more
    Mar 26, 2021

    Non-small-cell Lung Cancer Trial in France (Pembrolizumab, Pembrolizumab and Chemotherapy drugs)

    Recruiting
    • Non-small-cell Lung Cancer
    • Aix-en-Provence, France
    • +30 more
    Mar 10, 2021

    Non-Small-Cell Lung Cancer Trial (Camrelizumab, Placebo, Cisplatin)

    Not yet recruiting
    • Non-Small-Cell Lung Cancer
    • (no location specified)
    Feb 22, 2021

    Non-small-cell Lung Cancer Trial in Guangzhou (Nimotuzumab, docetaxel and cisplatin, daily RT to the chest)

    Completed
    • Non-small-cell Lung Cancer
    • Guangzhou, Guangdong, China
      Sun yat-sen University Cancer Center
    Feb 8, 2021

    Non-small-cell Lung Cancer Trial in Shanghai (pyrotinib combined with thalidomide)

    Recruiting
    • Non-small-cell Lung Cancer
    • pyrotinib combined with thalidomide
    • Shanghai, China
      Department of Oncology, Shanghai Lung Cancer Center, Shanghai Ch
    Jan 26, 2021

    Non-Small-Cell Lung Cancer Trial (SHR-1701,Famitinib, SHR-1701)

    Not yet recruiting
    • Non-Small-Cell Lung Cancer
    • (no location specified)
    Jan 5, 2021

    Non-Small-Cell Lung Cancer Trial (SHR-1701+Paclitaxel+carboplatin, SHR-1701)

    Not yet recruiting
    • Non-Small-Cell Lung Cancer
    • (no location specified)
    Oct 6, 2020

    Non-Small-Cell Lung Cancer Trial (SHR1701)

    Unknown status
    • Non-Small-Cell Lung Cancer
    • (no location specified)
    Sep 17, 2020

    Non-small-cell Lung Cancer Trial in Shanghai (gefitinib combined with chemo, gefitinib combined with apatinib, gefitinib single

    Unknown status
    • Non-small-cell Lung Cancer
    • gefitinib combined with chemotherapy
    • +2 more
    • Shanghai, Shanghai, China
      Shanghai Pulmonary Hospital;
    Jul 31, 2020

    Non-small-cell Lung Cancer, Mesothelioma Trial in Wuhan (aPD1-MSLN-CAR T cells)

    Recruiting
    • Non-small-cell Lung Cancer
    • Mesothelioma
    • αPD1-MSLN-CAR T cells
    • Wuhan, Hubei, China
      Union Hospital affiliated to Tongji Medical College of Huazhong
    Jul 27, 2020

    Lung Diseases, Tumors, Respiratory Tract Diseases Trial (Sintilimab injection)

    Unknown status
    • Lung Diseases
    • +4 more
    • Sintilimab injection
    • (no location specified)
    Apr 29, 2020

    Breast Cancer, Pancreatic Cancer, Colorectal Cancer Trial in Oklahoma City, Nashville (MORAb-066)

    Completed
    • Breast Cancer
    • +5 more
    • Oklahoma City, Oklahoma
    • +1 more
    Apr 14, 2020

    Carcinoma, Non-small-cell Lung Cancer, Lung Tumors Trial in Beijing

    Completed
    • Carcinoma
    • +2 more
      • Beijing, Beijing, China
        Peking University People's Hospital
      Mar 26, 2020

      Non-Small-Cell Lung Cancer Trial in Jinan (SHR-1210)

      Unknown status
      • Non-Small-Cell Lung Cancer
      • Jinan, Shandong, China
        Shandong Cancer Hospital and Institute
      Feb 3, 2020

      Gastric Cancer, Hepatocellular Carcinoma, Non-Small-Cell Lung Cancer Trial in Chengdu (DC vaccine subcutaneous administration)

      Recruiting
      • Gastric Cancer
      • +3 more
      • DC vaccine subcutaneous administration
      • Chengdu, Sichuan, China
        Qiu Li
      Oct 30, 2019

      Lung Diseases, Tumors, Respiratory Tract Diseases Trial in Chengdu (Apatinib, SHR-1210)

      Unknown status
      • Lung Diseases
      • +4 more
      • Chengdu, Sichuan, China
        Sichuan Cancer Hospital
      Oct 17, 2019

      Identifying Genomic Mutations of Multiple Primary Lung Cancers

      Unknown status
      • Carcinoma
      • +2 more
        • (no location specified)
        Aug 26, 2019

        Lung Cancer, Non-Small Cell, Non-Small-Cell Lung Cancer Trial in Canada, Poland, United States (Topotecan/Docetaxel combination,

        Completed
        Has Results
        • Lung Cancer, Non-Small Cell
        • Non-Small-Cell Lung Cancer
        • Huntsville, Alabama
        • +84 more
        Mar 29, 2019

        Non-small-cell Lung Cancer, Radiation Pneumonitis Trial in Aarhus (SPECT-based treatment plan)

        Completed
        • Non-small-cell Lung Cancer
        • Radiation Pneumonitis
        • SPECT-based treatment plan
        • Aarhus, Denmark
          Department of Oncology, Aarhus University Hospital
        Apr 23, 2019

        Non-Small-Cell Lung Cancer Trial in Japan (Gilteritinib, Erlotinib)

        Terminated
        Has Results
        • Non-Small-Cell Lung Cancer
        • Fukuoka Minami-ku, Fukuoka, Japan
        • +3 more
        Jan 21, 2019

        Small Pulmonary Nodules by Multi-omics Sequencing

        Completed
        • Carcinoma
        • +2 more
          • Beijing, Beijing, China
            Peking University People's Hospital
          Jan 8, 2019

          Non-Small-Cell Lung Cancer Trial (Anlotinib)

          Unknown status
          • Non-Small-Cell Lung Cancer
          • (no location specified)
          Nov 1, 2018

          Non-Small-Cell Lung Cancer Trial in Germany, Italy (LY573636-sodium)

          Completed
          Has Results
          • Non-Small-Cell Lung Cancer
          • Gauting, Germany
          • +6 more
          Mar 17, 2018

          Initial Oral Vinorelbine Dosing Schedules in Clinical Routine in

          Completed
          • Non-Small-Cell Lung Cancer
          • Breast Cancer
          • Vinorelbine oral
          • Braunau Am Inn, Austria
          • +55 more
          Aug 28, 2018